Takeover

Acquirers

Zevra Therapeutics, Inc.

Targets
1
Filings
1
Median premium
100%
First filing
Oct 10, 2023
Latest filing
Oct 10, 2023

Targets

CompanyScore before dealScore nowFilingsLatest
Acer Therapeutics Inc.——1Oct 10, 2023

Deal filings

FiledCompanyFormPricePremium
Oct 10, 2023Acer Therapeutics Inc.DEFM14A$5.30100%